This review aims to evaluate the current preclinical state of liver bioengineering, the clinical context for liver cell therapies, the cell sources, the delivery routes, and the results of clinical trials for end-stage liver disease. Different clinical settings, such as inborn errors of metabolism, acute liver failure, chronic liver dis-ease, liver cirrhosis, and acute-on-chronic liver failure, as well as multiple cellular sources were analyzed; namely, hepatocytes, he-patic progenitor cells, biliary tree stem/progenitor cells, mesen-chymal stromal cells, and macrophages. The highly heterogeneous clinical scenario of liver disease and the availability of multiple cellular sources endowed with different biological properties make this a multidisciplinary translational research challenge. Data on each individual liver disease and more accurate endpoints are urgently needed, together with a characterization of the regen-erative pathways leading to potential therapeutic benefit. Here, we critically review these topics and identify related research needs and perspectives in preclinical and clinical settings.

Cardinale, V., Lanthier, N., Baptista, P., Carpino, G., Carnevale, G., Orlando, G., et al. (2023). Cell transplantation-based regenerative medicine in liver diseases. STEM CELL REPORTS, 18(8), 1555-1572 [10.1016/j.stemcr.2023.06.005].

Cell transplantation-based regenerative medicine in liver diseases

Angelico, R;Manzia, TM;
2023-08-08

Abstract

This review aims to evaluate the current preclinical state of liver bioengineering, the clinical context for liver cell therapies, the cell sources, the delivery routes, and the results of clinical trials for end-stage liver disease. Different clinical settings, such as inborn errors of metabolism, acute liver failure, chronic liver dis-ease, liver cirrhosis, and acute-on-chronic liver failure, as well as multiple cellular sources were analyzed; namely, hepatocytes, he-patic progenitor cells, biliary tree stem/progenitor cells, mesen-chymal stromal cells, and macrophages. The highly heterogeneous clinical scenario of liver disease and the availability of multiple cellular sources endowed with different biological properties make this a multidisciplinary translational research challenge. Data on each individual liver disease and more accurate endpoints are urgently needed, together with a characterization of the regen-erative pathways leading to potential therapeutic benefit. Here, we critically review these topics and identify related research needs and perspectives in preclinical and clinical settings.
8-ago-2023
Pubblicato
Rilevanza internazionale
Recensione
Esperti anonimi
Settore MED/18
Settore MEDS-06/A - Chirurgia generale
English
stem cells; scaffolds; progenitors; macrophages; hepatocytes; cirrhosis; acute liver failure; cell therapy
Cardinale, V., Lanthier, N., Baptista, P., Carpino, G., Carnevale, G., Orlando, G., et al. (2023). Cell transplantation-based regenerative medicine in liver diseases. STEM CELL REPORTS, 18(8), 1555-1572 [10.1016/j.stemcr.2023.06.005].
Cardinale, V; Lanthier, N; Baptista, P; Carpino, G; Carnevale, G; Orlando, G; Angelico, R; Manzia, T; Schuppan, D; Pinzani, M; Alvaro, D; Ciccocioppo,...espandi
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
main.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 3.18 MB
Formato Adobe PDF
3.18 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/344830
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 7
social impact